Unwelcome Complement

The complement system can be activated through three distinctive pathways: The classical pathway (CP) is initiated when C1q binds to its various targets. Bound C1q activates C1r and C1s within the C1 complex, and C1s then cleaves C2 and C4. The lectin pathway (LP) begins with the binding of mannose-binding lectin (MBL) or ficolins to pathogen-associated molecular patterns (PAMPs) or apoptotic host cells. This binding activates MBL-associated serine proteases (MASPs), which cleave C4, generating C4a (which is released) and C4b. As a result of the cleavage of C2 and C4 by the CP or LP, C4b combines with C2a to form the CP C3 convertase, which cleaves C3 into C3a and C3b. The alternative pathway (AP) is initiated by low-grade cleavage of C3 in plasma and the generation of a small amount of C3b. This C3b binds factor B (fB), which is then cleaved into Ba and Bb. This cleavage leads to the formation of the “initial” AP C3 convertase, which, like the CP convertase, cleaves C3 into C3a and C3b. C3a is released, and C3b binds to activating surfaces. Surface-bound C3b binds additional fB, which is cleaved within this complex, leading to the formation of the AP C3 convertase. The C3 convertase can amplify complement activation induced by the CP or LP. C3b can bind to C4b2a or C3bBb to form the CP or AP (not shown) C5 convertase, respectively, which cleave C5 into C5a and C5b. The C5a is released, and C5b contributes, together with C6–C9, to the formation of the terminal complement complex (TCC). Complement effectors generated during activation can limit tumor growth. The C3b cleavage product iC3b binds to tumor cells, and through its interaction with complement receptor (CR) 3 on mononuclear phagocytes and natural killer (NK) cells enhances antibody-dependent cellular cytotoxicity (ADCC). The TCC is thought to contribute to complement-dependent cytotoxicity (CDC), which is one of the mechanisms for eliminating tumor cells by means of therapeutic antibodies. Some complement proteins accelerate tumor growth. C5a probably generated through the CP, recruits neutrophil-like myeloid-derived suppressor cells (PMN-MDSCs) to tumors. PMN-MDSCs migrate to tumors and produce highly immunosuppressive reactive oxygen species (ROS) and reactive nitrogen species (RNS) that inhibit the anti-tumor T-cell response. In addition, C5a enhances the production of ROS and RNS by monocyte-like myeloid-derived suppressor cells (MO-MDSCs) in the tumor microenvironment. Tumor cells are protected from complement attack by membrane complement regulatory proteins (mCRPs) and soluble complement inhibitors, secreted in the tumor microenvironment, such as factor H (fH) and factor I (fI). Factor H is a cofactor for fI-mediated cleavage of C3b to iC3b and accelerates the decay of the alternative pathway C3 convertase.
Unwelcome Complement

Publication

Unwelcome Complement. () Maciej M. Markiewski, et al. Cancer Res. ;69(16):6367-6370. Figure: F1.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates RNS RNS ncbigene_synonym FAM20C 56975
Homo sapiens Primates fH FH ncbigene_symbol FH 2271
Homo sapiens Primates C4a C4A ncbigene_symbol C4A 720
Homo sapiens Primates СЗа C3 ncbigene_symbol C3 718
Homo sapiens Primates MASP1 MASP1 ncbigene_symbol MASP1 5648
Homo sapiens Primates C5a C5A ncbigene_synonym C5 727
Homo sapiens Primates C5a C5A ncbigene_synonym C5AR1 728
Homo sapiens Primates MASP2 MASP2 ncbigene_symbol MASP2 10747
Homo sapiens Primates MBL MBL ncbigene_synonym MBL2 4153
Homo sapiens Primates MBL MBL ncbigene_synonym MBL3P 50639
Homo sapiens Primates TCC TCC ncbigene_synonym SFXN1 94081
Mus musculus Rodents fH FH ncbigene_symbol fh 14193
Mus musculus Rodents C4a C4A ncbigene_symbol C4a 625018
Mus musculus Rodents СЗа C3 ncbigene_symbol C3 12266
Mus musculus Rodents MASP1 MASP1 ncbigene_symbol Masp1 17174
Mus musculus Rodents C5a C5A ncbigene_synonym Hc 15139
Mus musculus Rodents MASP2 MASP2 ncbigene_symbol Masp2 17175
Mus musculus Rodents MBL MBL ncbigene_synonym Mbl2 17195
Mus musculus Rodents TCC TCC ncbigene_synonym Cyct 13067
Drosophila melanogaster Invertebrates fВ FB ncbigene_symbol fb 250310
Drosophila melanogaster Invertebrates fВ FB ncbigene_synonym anon-16Fa 5657870
Drosophila melanogaster Invertebrates fl FL ncbigene_symbol fl 45853
Drosophila melanogaster Invertebrates fl FI ncbigene_symbol fi 248652
Drosophila melanogaster Invertebrates fH FH ncbigene_symbol fh 31845
Drosophila melanogaster Invertebrates MBL MBL ncbigene_symbol mbl 36945
Drosophila melanogaster Invertebrates CDC CDC ncbigene_synonym Cdk1 34411
Drosophila melanogaster Invertebrates and AND ncbigene_synonym CkIIbeta 32132
Drosophila melanogaster Invertebrates and AND ncbigene_synonym Andorra 32798
Drosophila melanogaster Invertebrates and AND ncbigene_synonym Anp 43595
Drosophila melanogaster Invertebrates and AND ncbigene_synonym Acam 44913
Danio rerio Vertebrates fH FH ncbigene_symbol fh 393938
Danio rerio Vertebrates MASP1 MASP1 ncbigene_symbol masp1 100002060
Danio rerio Vertebrates C4 C4 ncbigene_symbol c4 566261
Danio rerio Vertebrates MASP2 MASP2 ncbigene_symbol masp2 560277
Danio rerio Vertebrates MBL MBL ncbigene_synonym hbl1 100007982
Danio rerio Vertebrates MBL MBL ncbigene_synonym mbl2 100008009
Danio rerio Vertebrates lectin LECTIN ncbigene_symbol lectin 560034

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID